Company Filing History:
Years Active: 2014
Title: Innovations of John Cousins in Cancer Detection
Introduction
John Cousins is an accomplished inventor based in Albuquerque, NM. He has made significant contributions to the field of medical diagnostics, particularly in the detection of cancerous cells. His innovative approach combines advanced labeling techniques with imaging technology to improve the accuracy of cancer detection.
Latest Patents
John Cousins holds a patent for a "System and method for analyzing samples labeled with 5, 10, 15, 20 tetrakis (4-carboxyphenyl) porphine (TCPP)." This invention provides a method for determining if a sputum sample contains dysplastic or carcinomic cells. The process involves labeling the sputum sample with TCPP to stain cells suspected of being dysplastic or carcinomic. The sample is then excited with a specific wavelength of light, allowing for the detection of emission from macrophages and potentially cancerous cells. This innovative method enhances the ability to identify cancerous cells through precise imaging and scoring techniques.
Career Highlights
John Cousins is currently employed at Bioaffinity Technologies, Inc., where he continues to develop and refine his innovative methods for cancer detection. His work has the potential to significantly impact the field of medical diagnostics, providing healthcare professionals with better tools for early detection of cancer.
Collaborations
Some of his notable coworkers include Constance Dorian and Gordon Bennett, who contribute to the collaborative environment at Bioaffinity Technologies, Inc. Their combined expertise fosters innovation and advances in cancer detection technologies.
Conclusion
John Cousins is a pioneering inventor whose work in cancer detection exemplifies the intersection of technology and healthcare. His patented methods offer promising advancements in the early diagnosis of cancer, potentially saving lives through improved detection techniques.